1 enrolling by invitation. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow Nasal Surgical Procedures: new trials by email Literature Review of Nasal Surgical Procedures trials Research Report on Nasal Surgical Procedures
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antibiotic Prophylaxis in Rhinoplasty Intra-operative single intravenous(iv) dose of "cephalexin" 2 g or "clindamycin" 900 mg., Intra-operative single dose (iv) of "cephalexin" 2 g or "clindamycin" 900 mg and postoperative oral dose of "cephalexin" 250mg (every 4 hours) or "clindamycin" 150mg(every 6 hours) for 3 days - Nasal Obstruction, Nasal Surgical Procedures | Phase 3 | Enrolling by invitation | Stanford University | 864 | 2020-05-20 | 2026-04-24 |
Airway Obstruction (1) · Nose Diseases (1) · Otorhinolaryngologic Diseases (1) · Respiration Disorders (1) · Respiratory Insufficiency (1) · Respiratory Tract Diseases (1)
Cephalexin (1) · Clindamycin (1)
United States (1)
Sam P Most, MD (1)